Morgan Stanley Abbott Laboratories Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Abbott Laboratories stock. As of the latest transaction made, Morgan Stanley holds 35,206,652 shares of ABT stock, worth $4.61 Billion. This represents 0.32% of its overall portfolio holdings.
Number of Shares
35,206,652
Previous 36,136,810
2.57%
Holding current value
$4.61 Billion
Previous $4.79 Billion
0.11%
% of portfolio
0.32%
Previous 0.35%
Shares
24 transactions
Others Institutions Holding ABT
# of Institutions
3,590Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22.6 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.3 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.88 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.47 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...